BNP Paribas Exane raises Salesforce stock price target to $230 By Investing.com

Salesforce authorized a $50B repurchase and commenced a $25B accelerated share repurchase (initial delivery ~103M shares), funded by a $25B senior notes sale (eight tranches, 4.50%-6.70% maturities 2028–2066). BNP Paribas Exane raised its price target to $230 (from $220) and increased its FY27 buyback estimate to ~$25B (vs $16B prior), modeling a ~8% diluted share count reduction and $20B of repurchases in Q1 FY27. Offsets include modeled interest expense rising to ~$1.7B in FY27, EPS cuts of ~2% (FY27) and ~3% (FY28) on GAAP, and net debt/NTM EBITDA rising to ~1.7x from 0.4x. Wolfe Research reiterated Outperform, citing Slackbot as a product catalyst; stock trading near $185.33 (52-week low $174.57) with InvestingPro fair value ~$275.53.

Analysis

Selling large amounts of stock via accelerated repurchases funded with new debt is a classic short-term EPS lever that mechanically tightens float and amplifies earnings per share volatility. That creates a near-term technical bid (smaller float + buyback flow) but shifts enterprise sensitivity from revenue growth to interest-rate and credit-market moves — the company’s operating leverage now cohabits with material fixed financing costs, increasing downside tail-risk if macro credit premiums reprice.

On the competitive front, product innovation (e.g., advanced bots and AI assistants) is necessary to justify higher revenue multiple, but commercialization lags integration and upsell cycles; incumbents with broader bundles can blunt penetration by tying similar features into suites, pressuring seat pricing and upsell velocity. A secondary effect: reduced public float concentrates ownership among strategic holders and quant/momentum funds, which raises intraday gamma and liquidity-driven gaps around earnings or macro shocks.

Key catalysts span very different horizons: within days–weeks, tranche execution and dealer hedging can drive outsize price moves; over quarters, subscription retention and cross-sell cadence will prove whether buybacks bought sustainable growth or only temporary EPS optics. Contrarian risk — the market is rewarding capital returns as if they were free cash growth; if interest costs continue to ratchet up or growth moderates, multiples could re-rate quickly, undoing much of the buyback-driven uplift within 6–12 months.

Key Decisions for Investors

• Long CRM with asymmetric hedge: buy shares sized to 0.75–1.5% of portfolio and simultaneously purchase a 6–9 month put ~10% OTM sized to cap downside to ~2% portfolio risk; target a 20–30% upside over 9–12 months if product execution holds while limiting drawdown from a credit repricing shock.
• Call-spread trade to play float compression: buy a 12-month CRM 25–35% OTM call spread sized for 0.5% portfolio risk. This captures an accelerated buyback squeeze / positive sentiment move while bounding premium decay; expect 3:1+ payoff if catalysts validate.
• Pairs trade to neutralize macro/AI beta: long CRM / short MSFT (equal notional tech exposure) for 6–12 months to isolate CRM-specific buyback/Slack monetization upside. Size to risk 1% of portfolio and monitor relative retention and seat growth; unwind on 6% divergent move against the pair.
• Credit watch / event hedge: if investment-grade or convertible bond spreads for the issuer widen by >50bps, sell half of long exposures and buy IG corporate bond protection (CDS or short-duration HY ETF) to hedge funding-cost shock that would reverse EPS gains over 3–9 months.
• Options gamma capture around tranche completion: sell short-dated call spreads into expected buyback flow windows to collect premium from transient implied-volatility spikes, limiting max loss via defined-width spreads; keep exposure small (<=0.5% portfolio) given execution and liquidity risk.